Amir is a globally recognized physician-scientist and innovator at the intersection of life sciences and technology. He serves as a board director and advisor to private and public companies, universities and investment groups in the life sciences and tech sectors.

Amir is Co-Chair of the Decentralized Trials and Research Alliance (DTRA) and Chairman of the CNS Summit, a forum focused on the future of life sciences. He was also the Founding Chairman of the International Society for CNS Drug Development (ISCDD) and serves on its Executive Committee.

Amir is a Professor of Psychiatry at the University of California San Diego and Editor of Innovations in Clinical Neuroscience. He has authored over 250 peer-reviewed publications and is the Lead Editor of Essential CNS Drug Development, published by Cambridge University Press. Previously, he led the Neuroscience Center of Excellence at Quintiles (now IQVIA) for nearly 20 years, where he oversaw numerous successful drug development programs. His contributions have been recognized by The Medicine Maker’s Power List and PharmaVOICE’s Red Jacket award.

Amir is a frequent speaker at scientific meetings, addressing topics like drug development, digital medicine, clinical trials, and biohacking.